1. de Lange, Katrina M, Moutsianas, Loukas, Lee, James C, Anderson, Carl A, Barrett, Jeffrey C. 2017. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease. In Nature genetics, 49, 256-261. doi:10.1038/ng.3760. https://pubmed.ncbi.nlm.nih.gov/28067908/
2. Zhang, Ruihao, Zhu, Guangsheng, Li, Zaishan, Liu, Hongyu, Chen, Jun. 2024. ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltrates. In Frontiers in immunology, 15, 1382231. doi:10.3389/fimmu.2024.1382231. https://pubmed.ncbi.nlm.nih.gov/38646528/
3. Li, Ran, Wu, Xiaolu, Xue, Kai, Li, Junmin. 2022. ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemia. In Cancer cell international, 22, 268. doi:10.1186/s12935-022-02684-x. https://pubmed.ncbi.nlm.nih.gov/35999614/
4. Zhang, Junchang, Wang, Han, Yuan, Cheng, Zhang, Changhua, He, Yulong. 2022. ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer. In Frontiers in cell and developmental biology, 10, 808212. doi:10.3389/fcell.2022.808212. https://pubmed.ncbi.nlm.nih.gov/35399517/
5. Glawe, John D, Patrick, D Ross, Huang, Meng, Barlow, Shayne C, Kevil, Christopher G. 2009. Genetic deficiency of Itgb2 or ItgaL prevents autoimmune diabetes through distinctly different mechanisms in NOD/LtJ mice. In Diabetes, 58, 1292-301. doi:10.2337/db08-0804. https://pubmed.ncbi.nlm.nih.gov/19223596/